Molecule News and Research

RSS

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision.

7 Sep 2023

Biosciences: how nature is changing the future of drug discovery

In this new podcast, Bruker's Kate Stumpo talks with Enveda's Pelle Simpson on the opportunities of natural products in the field of multiomics.

From Bruker Daltonics 6 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson's disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.

4 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

SparkMaster 2: New software automates analysis of calcium release events

A team of UC Davis and University of Oxford researchers have developed an innovative tool: SparkMaster 2.

1 Sep 2023

Study sheds light on immune cells' ability to collectively migrate through complex environments

When fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) now discovered that immune cells actively generate their own guidance system to navigate through complex environments.

1 Sep 2023

Scientists delve deeper into how vaccines work against leishmaniasis

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.

31 Aug 2023

Universal approach could potentially expand CAR T cell therapy to all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer.

31 Aug 2023

Maternal high-fat diet may alter airway nerves in offspring, leading to asthma

New research points to a novel potential mechanism behind eating a high-fat diet during pregnancy and asthma in the offspring.

31 Aug 2023

Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC.

From Optibrium Ltd. 31 Aug 2023

ADHD drug could serve as a cocaine-replacement therapy

Cocaine use continues to be a public health problem, yet despite concerted efforts, no drugs have been approved to resolve cocaine addiction. Research suggests that the attention-deficit/hyperactivity disorder drug methylphenidate (MPH; Ritalin) could serve as a cocaine-replacement therapy, but clinical results have been mixed.

30 Aug 2023

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Researchers evaluated the tolerability, safety, pharmacodynamics, and pharmacokinetic properties of muvalaplin.

30 Aug 2023

Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, today announced that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.

30 Aug 2023

New drug candidate reduces inflammation and improves memory in Alzheimer's mouse models

Though drug developers have achieved some progress in treating Alzheimer's disease with medicines that reduce amyloid-beta protein, other problems of the disease including inflammation, continue unchecked.

29 Aug 2023

TBI-on-a-chip model traces link between head trauma and Alzheimer's

How much time elapses between a blow to the head and the start of damage associated with Alzheimer's disease?

29 Aug 2023

Same cellular mechanism implicated in cystic fibrosis and rare disease cystinosis

University of Michigan researchers have discovered that the same cellular mechanism involved in a form of cystic fibrosis is also implicated in a form of a rare disease called cystinosis.

28 Aug 2023

U.S. Army develops broad-spectrum snakebite antidote for use in austere environments

Members of the Warfighter Protection and Acute Care Project Management Office were recognized for program management excellence during the annual Military Health System Research Symposium in Kissimmee, Florida, Aug. 14.

28 Aug 2023

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University's Victorian Heart Institute and Victorian Heart Hospital.

28 Aug 2023

A review of the neurological imaging techniques in dementia diagnosis

Researchers reviewed existing data on the contribution of neuroimaging modalities such as magnetic resonance imaging.

28 Aug 2023

Molecule News and Research

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

Biosciences: how nature is changing the future of drug discovery

How is next-generation protein sequencing democratizing protein sequencing?

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

SparkMaster 2: New software automates analysis of calcium release events

Study sheds light on immune cells' ability to collectively migrate through complex environments

Scientists delve deeper into how vaccines work against leishmaniasis

Universal approach could potentially expand CAR T cell therapy to all blood cancers

Maternal high-fat diet may alter airway nerves in offspring, leading to asthma

Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

ADHD drug could serve as a cocaine-replacement therapy

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

New drug candidate reduces inflammation and improves memory in Alzheimer's mouse models

TBI-on-a-chip model traces link between head trauma and Alzheimer's

Same cellular mechanism implicated in cystic fibrosis and rare disease cystinosis

U.S. Army develops broad-spectrum snakebite antidote for use in austere environments

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

A review of the neurological imaging techniques in dementia diagnosis

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News